These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 37310570

  • 1. Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists.
    Wada T, Shimizu S, Koizumi M, Sofue T, Nishiwaki H, Sasaki S, Nakaya I, Oe Y, Ishimoto T, Furuichi K, Okada H, Kurita N.
    Clin Exp Nephrol; 2023 Sep; 27(9):767-775. PubMed ID: 37310570
    [Abstract] [Full Text] [Related]

  • 2. Variations in actual practice patterns and their deviations from the clinical practice guidelines for nephrotic syndrome in Japan: certified nephrologists' questionnaire survey.
    Niihata K, Nishiwaki H, Kurita N, Okada H, Maruyama S, Narita I, Shibagaki Y, Nakaya I.
    Clin Exp Nephrol; 2019 Nov; 23(11):1288-1297. PubMed ID: 31385161
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 4. Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020.
    Sasaki S, Shimizu S, Nakaya I, Miyaoka Y, Koizumi M, Nishiwaki H, Sofue T, Ishimoto T, Kurita N, Wada T.
    Clin Exp Nephrol; 2024 Jun; 28(6):531-538. PubMed ID: 38402500
    [Abstract] [Full Text] [Related]

  • 5. Japanese clinical practice patterns of rituximab treatment for minimal change disease in adults 2021: A web-based questionnaire survey of certified nephrologists.
    Koizumi M, Ishimoto T, Shimizu S, Sasaki S, Kurita N, Wada T.
    PLoS One; 2024 Jun; 19(3):e0299053. PubMed ID: 38551948
    [Abstract] [Full Text] [Related]

  • 6. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
    Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
    Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
    [Abstract] [Full Text] [Related]

  • 7. Regional variations in immunosuppressive therapy in patients with primary nephrotic syndrome: the Japan nephrotic syndrome cohort study.
    Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Yoshio T, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
    Clin Exp Nephrol; 2018 Dec; 22(6):1266-1280. PubMed ID: 29679356
    [Abstract] [Full Text] [Related]

  • 8. Pharmacologic management of adult idiopathic nephrotic syndrome.
    Alaniz C, Brosius FC, Palmieri J.
    Clin Pharm; 1993 Jun; 12(6):429-39. PubMed ID: 8403814
    [Abstract] [Full Text] [Related]

  • 9. Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists.
    Miyaoka Y, Kurita N, Sofue T, Nishiwaki H, Koizumi M, Shimizu S, Sasaki S, Ishimoto T, Wada T.
    Clin Exp Nephrol; 2024 Mar; 28(3):217-224. PubMed ID: 37924431
    [Abstract] [Full Text] [Related]

  • 10. Treatment of the nephrotic syndrome with cyclosporin A.
    Ponticelli C.
    J Autoimmun; 1992 Apr; 5 Suppl A():315-24. PubMed ID: 1503627
    [Abstract] [Full Text] [Related]

  • 11. The increasing incidence of initial steroid resistance in childhood nephrotic syndrome.
    Banaszak B, Banaszak P.
    Pediatr Nephrol; 2012 Jun; 27(6):927-32. PubMed ID: 22231438
    [Abstract] [Full Text] [Related]

  • 12. Nephrotic Syndrome After Hematopoietic Stem Cell Transplant: Outcomes in Iran.
    Saddadi F, Alidadi A, Hakemi M, Bahar B.
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):90-92. PubMed ID: 28260442
    [Abstract] [Full Text] [Related]

  • 13. [Effect of cyclosporin A on renal function in patients with glomerulonephritis].
    Heering P, Schneider A, Grabensee B, Plum J.
    Dtsch Med Wochenschr; 2001 Oct 05; 126(40):1093-8. PubMed ID: 11588659
    [Abstract] [Full Text] [Related]

  • 14. [Indications for cyclosporin in the treatment of idiopathic nephrotic syndrome in adults].
    Zietse R, Weimar W.
    Ned Tijdschr Geneeskd; 1992 Sep 05; 136(36):1749-53. PubMed ID: 1407123
    [No Abstract] [Full Text] [Related]

  • 15. Rationale and design of the Japanese Biomarkers in Nephrotic Syndrome (J-MARINE) study.
    Kurasawa S, Kato S, Ozeki T, Akiyama S, Ishimoto T, Mizuno M, Tsuboi N, Kato N, Kosugi T, Maruyama S, J-MARINE collaborators.
    Clin Exp Nephrol; 2024 May 05; 28(5):431-439. PubMed ID: 38267800
    [Abstract] [Full Text] [Related]

  • 16. Population-based identification and temporal trend of children with primary nephrotic syndrome: The Kaiser Permanente nephrotic syndrome study.
    Parikh RV, Tan TC, Fan D, Law D, Salyer AS, Yankulin L, Wojcicki JM, Zheng S, Ordonez JD, Chertow GM, Khoshniat-Rad F, Yang J, Go AS.
    PLoS One; 2021 May 05; 16(10):e0257674. PubMed ID: 34648518
    [Abstract] [Full Text] [Related]

  • 17. [Advances in the treatment of adult nephrotic syndrome].
    Yokoyama H, Asaka M, Yamaya H, Wada T.
    Nihon Jinzo Gakkai Shi; 2007 May 05; 49(2):108-12. PubMed ID: 17375618
    [No Abstract] [Full Text] [Related]

  • 18. Cyclosporine in idiopathic nephrotic syndrome.
    Ponticelli C.
    Immunopharmacol Immunotoxicol; 1993 Aug 05; 15(4):479-89. PubMed ID: 8227973
    [Abstract] [Full Text] [Related]

  • 19. Substantial practice variation exists in the management of childhood nephrotic syndrome.
    Samuel S, Morgan CJ, Bitzan M, Mammen C, Dart AB, Manns BJ, Alexander RT, Erickson RL, Grisaru S, Wade AW, Blydt-Hansen T, Feber J, Arora S, Licht C, Zappitelli M.
    Pediatr Nephrol; 2013 Dec 05; 28(12):2289-98. PubMed ID: 23917450
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology of primary nephrotic syndrome in Egyptian children.
    Kaddah A, Sabry S, Emil E, El-Refaey M.
    J Nephrol; 2012 Dec 05; 25(5):732-7. PubMed ID: 22101675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.